The need for a critical review of the intellectual property system and incentives for medical innovation (June 2016)

Brussels, 2 June 2016 25 Civil Society organisations, including the Medicines in Europe Forum and the International Society of Drug Bulletins, call on Member States to resist pressure from the pharmaceutical industry to eliminate critical elements of proposed European Union (EU) Council Conclusions that would improve the balance between innovation and patients' access to affordable medicines.

Read more...

Member States ought to support the Dutch EU Presidency’s vision on access to affordable medicines (April 2016)

Amsterdam, 18 April 2016 20 civil society organisations including the Medicines in Europe Forum and ISDB announced their strong support for the Dutch European Union (EU) Presidency's critique of the current over-protection and misuse of intellectual property and related rights for pharmaceuticals. They also expressed support for efforts to better balance rewards for innovation against concerns over the affordability of medicines.

Read more...